Emergent Biosolutions (EBS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2010 | 12-2009 | 12-2008 | 12-2007 | 12-2006 | |
| Sales | 286,171 | 234,786 | 178,554 | 182,915 | 152,732 |
| Cost of Goods | 47,114 | 46,262 | 34,081 | 40,309 | 24,125 |
| Gross Profit | 239,057 | 188,524 | 144,473 | 142,606 | 128,607 |
| Operating Expenses | 165,614 | 148,636 | 114,627 | 109,822 | 90,704 |
| Operating Income | 73,557 | 40,150 | 29,927 | 33,093 | 38,028 |
| Interest Expense | 0 | 7 | 47 | 71 | 1,152 |
| Other Income | -191 | 1,368 | 2,133 | 2,965 | 1,139 |
| Pre-tax Income | 73,366 | 41,511 | 32,013 | 35,987 | 38,015 |
| Income Tax | 26,182 | 14,966 | 12,055 | 13,051 | 15,222 |
| Net Income Continuous | 47,184 | 26,545 | 19,958 | 22,936 | 22,793 |
| Minority Interests | -4,514 | -4,599 | -724 | N/A | N/A |
| Net Income | $51,698 | $31,144 | $20,682 | $22,936 | $22,793 |
| EPS Basic Total Ops | 1.63 | 1.02 | 0.69 | 0.79 | 0.99 |
| EPS Basic Continuous Ops | 1.48 | 0.87 | 0.67 | 0.79 | 0.99 |
| EPS Diluted Total Ops | 1.59 | 0.99 | 0.68 | 0.77 | 0.93 |
| EPS Diluted Continuous Ops | 1.45 | 0.85 | 0.66 | 0.77 | 0.93 |
| EBITDA(a) | $79,547 | $45,149 | $34,891 | $37,910 | $42,743 |